Book a demo

Company intelligence

BC3 Technologies

Biotechnology Research
Baltimore, US
8 employees
Founded 2018
5 public signals

About BC3 Technologies

BC3 Technologies (BC3T, focus is on developing novel and effective antihemorrhagic products for the medical, military, and general consumer sectors. BC3T’s proprietary chitosan-based aerosol product allows ease of application on wounds as well high-clotting ability which rivals against competitors’ products in both performance and cost. The biggest differentiator for BC3T’s technology compared to others is that the chitosan-based product has maximized hemostatic activity, great stability, and wide-range of applications.

Verified activity

Signals from BC3 Technologies

5 published signals

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

© 2026 SeedOpsCompany intelligence.

SeedOps.